Ann: Revised Payment Arrangements with DIAsource Vendors, page-159

I don't think the market realizes how big this deal with Cook could be , if the outcomes of the verification study continue to be compelling , could be enough to pay for DIA completely?
From last quarterly,
The previously disclosed feasibility study undertaken with Cook Medical Australia has been completed. The study outcomes were compelling and are now the subject of a fully funded verification study. Anteo welcomes the opportunity to continue to work with Cook Medical in applying our technologies to products that will ultimately lead to the improvement of health outcomes for patients.
In support of these activities, Anteo has embarked on an extensive internal program to re-formulate its chemistry with starting materials known to be safe for human use and compatible with in-vivo applications. One aspect is safety testing and a draft paper written by an Anteo collaborator has been prepared for peer-reviewed publication. The work relates to Mix&Go functionalised particles that have uses for clinical imaging or drug delivery, and part of this study confirms Mix&Go coatings have no observable toxicity to cells in vitro. These studies were using earlier versions of Anteo coatings and Anteo fully expects its re-formulation program will produce even safer and higher performing coatings/binders for in vivo and related applications